JSM Activity #402This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions. To View the Program: You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time. |
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2004 Program page |
Legend: = Applied Session,
= Theme Session,
= Presenter FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center |
||
402 | Thu, 8/12/04, 8:30 AM - 10:20 AM | TCC-713 A |
Data Monitoring Committees - Challenges - Topic Contributed - Papers | ||
Biopharmaceutical Section | ||
Organizer(s): Vipin K. Arora, Eli Lilly and Company | ||
Chair(s): John E. Connett, University of Minnesota | ||
8:35 AM | What is Enough? Preparation of DMC Reports on Interim Data — Marian R. Fisher, University of Wisconsin, Madison | |
8:55 AM | Clinical Trial DMCs: Flexible Approaches for Optimal Monitoring — Andreas Sashegyi, Eli Lilly and Company | |
9:15 AM | Clinical Trials Data-monitoring Committees: The Who, What, When, and Why of Unmasking — Anne S. Lindblad, EMMES Corporation | |
9:35 AM | How to Organize a Data Monitoring Committee and Prepare an Optimal Data Package? — Vipin K. Arora, Eli Lilly and Company; David Manner, Southwestern Medical School | |
9:55 AM | Disc: Joel Singer, University of British Columbia | |
10:15 AM | Floor Discussion | |
JSM 2004
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |